Inhibition of cellular activation induced by platelet factor 4 via the CXCR3 pathway ameliorates Japanese encephalitis and dengue viral infections.

CXCR3 DENV JEV autophagy infection interferon mice patients platelet factor 4

Journal

Journal of thrombosis and haemostasis : JTH
ISSN: 1538-7836
Titre abrégé: J Thromb Haemost
Pays: England
ID NLM: 101170508

Informations de publication

Date de publication:
27 Nov 2023
Historique:
received: 28 07 2023
revised: 05 11 2023
accepted: 10 11 2023
pubmed: 30 11 2023
medline: 30 11 2023
entrez: 29 11 2023
Statut: aheadofprint

Résumé

Activated platelets secrete platelet factor 4 (PF4), which contributes to viral pathogenesis. Recently, we reported the proviral role of PF4 in replication of closely related flaviviruses, Japanese encephalitis virus (JEV) and dengue virus (DENV). This study aimed to investigate the detailed mechanism of PF4-mediated virus replication. PF4 PF4 These studies suggest that PF4 deficiency or inhibition of the PF4:CXCR3 pathway prevents JEV and DENV infection. The studies also highlight the PF4:CXCR3 axis as a potential target to develop treatment regimens against flaviviruses.

Sections du résumé

BACKGROUND BACKGROUND
Activated platelets secrete platelet factor 4 (PF4), which contributes to viral pathogenesis. Recently, we reported the proviral role of PF4 in replication of closely related flaviviruses, Japanese encephalitis virus (JEV) and dengue virus (DENV).
OBJECTIVES OBJECTIVE
This study aimed to investigate the detailed mechanism of PF4-mediated virus replication.
METHODS METHODS
PF4
RESULTS RESULTS
PF4
CONCLUSION CONCLUSIONS
These studies suggest that PF4 deficiency or inhibition of the PF4:CXCR3 pathway prevents JEV and DENV infection. The studies also highlight the PF4:CXCR3 axis as a potential target to develop treatment regimens against flaviviruses.

Identifiants

pubmed: 38029855
pii: S1538-7836(23)00853-X
doi: 10.1016/j.jtha.2023.11.015
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2023 International Society on Thrombosis and Haemostasis. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interests All authors have no competing interests to disclose.

Auteurs

Anamika Singh (A)

Regional Centre for Biotechnology, National Capital Region Biotech Science Cluster, Faridabad, Haryana, India.

Riya Ghosh (R)

Regional Centre for Biotechnology, National Capital Region Biotech Science Cluster, Faridabad, Haryana, India.

Tejeswara Rao Asuru (TR)

Regional Centre for Biotechnology, National Capital Region Biotech Science Cluster, Faridabad, Haryana, India.

Surendra K Prajapat (SK)

Regional Centre for Biotechnology, National Capital Region Biotech Science Cluster, Faridabad, Haryana, India.

Garima Joshi (G)

Regional Centre for Biotechnology, National Capital Region Biotech Science Cluster, Faridabad, Haryana, India.

Kishan K Gaur (KK)

Regional Centre for Biotechnology, National Capital Region Biotech Science Cluster, Faridabad, Haryana, India.

Nishith M Shrimali (NM)

Regional Centre for Biotechnology, National Capital Region Biotech Science Cluster, Faridabad, Haryana, India.

Amrita Ojha (A)

Regional Centre for Biotechnology, National Capital Region Biotech Science Cluster, Faridabad, Haryana, India; Department of Medicine, Division of Infectious Diseases and Geographic Medicine, Stanford University, Stanford, California, USA.

Naval K Vikram (NK)

Division of Infectious Disease, All India Institute of Medical Sciences, New Delhi, India.

Mortimer Poncz (M)

Division of Hematology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.

Manjula Kalia (M)

Regional Centre for Biotechnology, National Capital Region Biotech Science Cluster, Faridabad, Haryana, India.

Prasenjit Guchhait (P)

Regional Centre for Biotechnology, National Capital Region Biotech Science Cluster, Faridabad, Haryana, India. Electronic address: prasenjit@rcb.res.in.

Classifications MeSH